1. Home
  2. ANIK vs NKTX Comparison

ANIK vs NKTX Comparison

Compare ANIK & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIK
  • NKTX
  • Stock Information
  • Founded
  • ANIK 1983
  • NKTX 2015
  • Country
  • ANIK United States
  • NKTX United States
  • Employees
  • ANIK N/A
  • NKTX N/A
  • Industry
  • ANIK Medical/Dental Instruments
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANIK Health Care
  • NKTX Health Care
  • Exchange
  • ANIK Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • ANIK 196.6M
  • NKTX 170.8M
  • IPO Year
  • ANIK 1993
  • NKTX 2020
  • Fundamental
  • Price
  • ANIK $14.02
  • NKTX $1.81
  • Analyst Decision
  • ANIK Buy
  • NKTX Strong Buy
  • Analyst Count
  • ANIK 2
  • NKTX 6
  • Target Price
  • ANIK $22.00
  • NKTX $15.00
  • AVG Volume (30 Days)
  • ANIK 77.6K
  • NKTX 2.5M
  • Earning Date
  • ANIK 05-07-2025
  • NKTX 05-08-2025
  • Dividend Yield
  • ANIK N/A
  • NKTX N/A
  • EPS Growth
  • ANIK N/A
  • NKTX N/A
  • EPS
  • ANIK N/A
  • NKTX N/A
  • Revenue
  • ANIK $119,907,000.00
  • NKTX N/A
  • Revenue This Year
  • ANIK N/A
  • NKTX N/A
  • Revenue Next Year
  • ANIK $8.72
  • NKTX N/A
  • P/E Ratio
  • ANIK N/A
  • NKTX N/A
  • Revenue Growth
  • ANIK N/A
  • NKTX N/A
  • 52 Week Low
  • ANIK $12.83
  • NKTX $1.31
  • 52 Week High
  • ANIK $29.12
  • NKTX $8.53
  • Technical
  • Relative Strength Index (RSI)
  • ANIK 41.05
  • NKTX 54.82
  • Support Level
  • ANIK $13.14
  • NKTX $1.67
  • Resistance Level
  • ANIK $14.32
  • NKTX $1.84
  • Average True Range (ATR)
  • ANIK 0.92
  • NKTX 0.14
  • MACD
  • ANIK 0.02
  • NKTX 0.03
  • Stochastic Oscillator
  • ANIK 45.42
  • NKTX 68.42

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

Share on Social Networks: